Circulation, Vol 81, 78-85, Copyright © 1990 by American Heart Association
LW Stevenson, K Sietsema, JH Tillisch, V Lem, J Walden, JA Kobashigawa and J Moriguchi
Cardiac transplantation is predicted to improve survival for patients with
severe symptoms of heart failure and ejection fraction of 20% or less, but
the exercise capacity after cardiac transplantation is less than normal.
Patients responding to vasodilators and diuretics have progressive
improvement in exercise capacity despite low ejection fraction. We
hypothesized that among patients currently considered appropriate for
transplantation who could nonetheless subsequently be stabilized on medical
therapy tailored to hemodynamic goals, survivors after 6 months of
sustained medical therapy would demonstrate exercise capacity comparable to
that of survivors of transplantation. Of 146 patients referred, 118 (81%)
were discharged on tailored therapy without transplantation, and 88 (60%)
were stable for at least 1 month. Stability after discharge was more likely
in patients with lower right atrial pressures and better renal function on
therapy. Of the 88 stable patients, 45 patients were listed for transplant,
and 43 were ineligible or unwilling. From these patients, 42 survivors for
more than 6 months follow-up after cardiac transplantation or tailoring of
medical therapy underwent exercise testing. Baseline functional and
hemodynamic status and left ventricular ejection fraction (15 +/- 4%) were
not different between the transplant and sustained medical survivor groups
at the time of initial evaluation. After 14 +/- 6 months, left ventricular
ejection fraction had increased to 62 +/- 7% after transplantation (p less
than 0.01) and only 22 +/- 9% after sustained medical therapy (p less than
0.05). However, there were no significant differences in the maximum
workload, oxygen uptake, anaerobic threshold, or maximum oxygen pulse
between survivors of cardiac transplantation and survivors on sustained
medical therapy.(ABSTRACT TRUNCATED AT 250 WORDS)
ARTICLES
Exercise capacity for survivors of cardiac transplantation or sustained medical therapy for stable heart failure
Division of Cardiology, UCLA School of Medicine 90024.
This article has been cited by other articles:
 |
|
 |
|
  A. Rossi, P. L. Temporelli, M. Quintana, F. L. Dini, S. Ghio, G. S. Hillis, A. L. Klein, N. Ajmone Marsan, D. L. Prior, C. M. Yu, et al. Independent relationship of left atrial size and mortality in patients with heart failure: an individual patient meta-analysis of longitudinal data (MeRGE Heart Failure) Eur J Heart Fail, October 1, 2009; 11(10): 929 - 936. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Chatterjee The Swan-Ganz Catheters: Past, Present, and Future: A Viewpoint Circulation, January 6, 2009; 119(1): 147 - 152. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. K. Andreassen Point:Counterpoint: Cardiac denervation does/does not play a major role in exercise limitation after heart transplantation J Appl Physiol, February 1, 2008; 104(2): 559 - 560. [Full Text] [PDF]
|
|
|
|
 |
|
 H. E. Verdejo, P. F. Castro, R. Concepcion, M. A. Ferrada, M. A. Alfaro, M. E. Alcaino, C. C. Deck, and R. C. Bourge Comparison of a Radiofrequency-Based Wireless Pressure Sensor to Swan-Ganz Catheter and Echocardiography for Ambulatory Assessment of Pulmonary Artery Pressure in Heart Failure J. Am. Coll. Cardiol., December 18, 2007; 50(25): 2375 - 2382. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Wasserman, X.-G. Sun, and J. E. Hansen Effect of Biventricular Pacing on the Exercise Pathophysiology of Heart Failure Chest, July 1, 2007; 132(1): 250 - 261. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. W. Stevenson, T. H. Le Jemtel, E. U. Alt, L. W. Stevenson, T. H. Le Jemtel, and E. U. Alt Hemodynamic Goals Are Relevant Circulation, February 21, 2006; 113(7): 1020 - 1033. [Full Text] [PDF]
|
|
|
|
 |
|
 The ESCAPE Investigators and ESCAPE Study Coordina Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness: The ESCAPE Trial JAMA, October 5, 2005; 294(13): 1625 - 1633. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Verdiani, C. Nozzoli, F. Bacci, A. Cecchin, M. S. Rutili, S. Paladini, and I. Olivotto Pre-discharge B-type natriuretic peptide predicts early recurrence of decompensated heart failure in patients admitted to a general medical unit Eur J Heart Fail, June 1, 2005; 7(4): 566 - 571. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. R. Shah, J. G. Rogers, G. A. Ewald, M. K. Pasque, E. M. Geltman, M. S. Bailey, and N. Moazami Survival of patients removed from the heart transplant waiting list J. Thorac. Cardiovasc. Surg., May 1, 2004; 127(5): 1481 - 1485. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Butler, G. Khadim, K. M. Paul, S. F. Davis, M. W. Kronenberg, D. B. Chomsky, R. N. Pierson III, and J. R. Wilson Selection of patients for heart transplantationin the current era of heart failure therapy J. Am. Coll. Cardiol., March 3, 2004; 43(5): 787 - 793. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. J. Eisen Hypertension in heart transplant recipients: more than just cyclosporine J. Am. Coll. Cardiol., February 5, 2003; 41(3): 433 - 434. [Full Text] [PDF]
|
|
|
|
|
|
M. R. Zile and D. L. Brutsaert New Concepts in Diastolic Dysfunction and Diastolic Heart Failure: Part II: Causal Mechanisms and Treatment Circulation, March 26, 2002; 105(12): 1503 - 1508. [Full Text] [PDF]
|
|
|
|
 |
|
 F. M. Bengel, P. Ueberfuhr, N. Schiepel, S. G. Nekolla, B. Reichart, and M. Schwaiger Effect of Sympathetic Reinnervation on Cardiac Performance after Heart Transplantation N. Engl. J. Med., September 6, 2001; 345(10): 731 - 738. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Hunt Reinnervation of the Transplanted Heart -- Why Is It Important? N. Engl. J. Med., September 6, 2001; 345(10): 762 - 764. [Full Text] [PDF]
|
|
|
|
 |
|
 K. Odaka, W. von Scheidt, S. I. Ziegler, P. Ueberfuhr, S. G. Nekolla, B. Reichart, F. M. Bengel, and M. Schwaiger Reappearance of Cardiac Presynaptic Sympathetic Nerve Terminals in the Transplanted Heart: Correlation Between PET Using 11C-Hydroxyephedrine and Invasively Measured Norepinephrine Release J. Nucl. Med., July 1, 2001; 42(7): 1011 - 1016. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. M. Bengel, P. Ueberfuhr, N. Schiepel, S. G. Nekolla, B. Reichart, and M. Schwaiger Myocardial Efficiency and Sympathetic Reinnervation After Orthotopic Heart Transplantation : A Noninvasive Study With Positron Emission Tomography Circulation, April 10, 2001; 103(14): 1881 - 1886. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-P. Cheng, T. Ukai, K. Onishi, N. Ohte, M. Suzuki, Z.-S. Zhang, H.-J. Cheng, H. Tachibana, A. Igawa, and W. C. Little The role of ANG II and endothelin-1 in exercise-induced diastolic dysfunction in heart failure Am J Physiol Heart Circ Physiol, April 1, 2001; 280(4): H1853 - H1860. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. A. Al-Rawas, R. Carter, R. D. Stevenson, S. K. Naik, and D. J. Wheatley Exercise Intolerance Following Heart Transplantation : The Role of Pulmonary Diffusing Capacity Impairment Chest, December 1, 2000; 118(6): 1661 - 1670. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Ewert, R. Wensel, L. Bruch, S. Mutze, U. Bauer, M. Plauth, and F.-X. Kleber Relationship Between Impaired Pulmonary Diffusion and Cardiopulmonary Exercise Capacity After Heart Transplantation Chest, April 1, 2000; 117(4): 968 - 975. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Uberfuhr, S. Ziegler, M. Schwaiblmair, B. Reichart, and M. Schwaiger Incomplete sympathic reinnervation of the orthotopically transplanted human heart: Observation up to 13 years after heart transplantation Eur. J. Cardiothorac. Surg., February 1, 2000; 17(2): 161 - 168. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Jaarsma, R. Halfens, H. H. Abu-Saad, K. Dracup, J. Stappers, and J. van Ree Quality of life in older patients with systolic and diastolic heart failure Eur J Heart Fail, June 1, 1999; 1(2): 151 - 160. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Pepi, P. Agostoni, G. Marenzi, E. Doria, M. Guazzi, G. Lauri, A. Maltagliati, and M. Guazzi The influence of diastolic and systolic function on exercise performance in heart failure due to dilated cardiomyopathy or ischemic heart disease Eur J Heart Fail, June 1, 1999; 1(2): 161 - 167. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Hunt Current Status of Cardiac Transplantation JAMA, November 18, 1998; 280(19): 1692 - 1698. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. de Groote, A. Millaire, C. Foucher-Hossein, O. Nugue, X. Marchandise, G.e. Ducloux, and J.-M. Lablanche Right ventricular ejection fraction is an independent predictor of survival in patients with moderate heart failure J. Am. Coll. Cardiol., October 1, 1998; 32(4): 948 - 954. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. E. Steimle, L. W. Stevenson, C. Chelimsky-Fallick, G. C. Fonarow, M. A. Hamilton, J. D. Moriguchi, A. Kartashov, and J. H. Tillisch Sustained Hemodynamic Efficacy of Therapy Tailored to Reduce Filling Pressures in Survivors With Advanced Heart Failure Circulation, August 19, 1997; 96(4): 1165 - 1172. [Abstract] [Full Text]
|
|
|
|
|
|
M. M. Givertz, L. H. Hartley, and W. S. Colucci Long-term Sequential Changes in Exercise Capacity and Chronotropic Responsiveness After Cardiac Transplantation Circulation, July 1, 1997; 96(1): 232 - 237. [Abstract] [Full Text]
|
|
|
|
 |
|
 E. Loh, J. V. Barnett, A. M. Feldman, G. S. Couper, D. E. Vatner, W. S. Colucci, and J. B. Galper Decreased Adenylate Cyclase Activity and Expression of Gs{alpha} in Human Myocardium After Orthotopic Cardiac Transplantation Circ. Res., May 1, 1995; 76(5): 852 - 860. [Abstract] [Full Text]
|
|